# Xiaoyan Ma

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/xiaoyan-ma/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,494 |
| Field | Dialysis and Renal Disease Management |
| h-index | 28 |
| i10-index | 57 |
| Last Known Institution | Shanghai East Hospital |
| OpenAlex ID | https://openalex.org/A5102770360 |
| ORCID iD | 0000-0003-0045-4320 |
| Works | 103 |

## Researcher papers

- [Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state](https://scholariq.org/papers/resistance-to-neoadjuvant-chemotherapy-in-triple-negative-breast-cancer-mediated/)
- [Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy](https://scholariq.org/papers/delayed-treatment-with-an-autophagy-inhibitor-3-ma-alleviates-the-progression-of/)
- [Allosteric SHP2 Inhibitor, IACS-13909, Overcomes EGFR-Dependent and EGFR-Independent Resistance Mechanisms toward Osimertinib](https://scholariq.org/papers/allosteric-shp2-inhibitor-iacs-13909-overcomes-egfr-dependent-and-egfr/)
- [An Upstream Open Reading Frame in Phosphatase and Tensin Homolog Encodes a Circuit Breaker of Lactate Metabolism](https://scholariq.org/papers/an-upstream-open-reading-frame-in-phosphatase-and-tensin-homolog-encodes-a/)
- [Blockade of Autophagy Prevents the Progression of Hyperuricemic Nephropathy Through Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis](https://scholariq.org/papers/blockade-of-autophagy-prevents-the-progression-of-hyperuricemic-nephropathy/)
- [Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury](https://scholariq.org/papers/inhibition-of-hdac6-protects-against-rhabdomyolysis-induced-acute-kidney-injury/)
- [Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage polarization](https://scholariq.org/papers/enhancer-of-zeste-homolog-2-promotes-renal-fibrosis-after-acute-kidney-injury-by/)
- [Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer](https://scholariq.org/papers/phase-ib-dose-expansion-and-translational-analyses-of-olaparib-in-combination/)
- [Peripherally inserted central catheter thrombosis incidence and risk factors in cancer patients: a double-center prospective investigation](https://scholariq.org/papers/peripherally-inserted-central-catheter-thrombosis-incidence-and-risk-factors-in/)
- [Functional Genomics Reveals Synthetic Lethality between Phosphogluconate Dehydrogenase and Oxidative Phosphorylation](https://scholariq.org/papers/functional-genomics-reveals-synthetic-lethality-between-phosphogluconate/)
- [A multicenter retrospective study on comparing the efficacy and safety of the therapy of intermittent cyclophosphamide and corticosteroids versus rituximab for primary membranous nephropathy](https://scholariq.org/papers/a-multicenter-retrospective-study-on-comparing-the-efficacy-and-safety-of-the/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [RNA Research and Splicing](https://scholariq.org/topics/rna-research-and-splicing/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)

## Researcher university

- [Shanghai East Hospital](https://scholariq.org/institutions/shanghai-east-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.